Search

Your search keyword '"de Hullu, Joanne"' showing total 21 results

Search Constraints

Start Over You searched for: Author "de Hullu, Joanne" Remove constraint Author: "de Hullu, Joanne" Publisher academic press Remove constraint Publisher: academic press
21 results on '"de Hullu, Joanne"'

Search Results

1. Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers.

2. Vulvar squamous cell carcinoma in women 80 years and older: Treatment, survival and impact of comorbidities.

3. The most efficient and effective BRCA1/2 testing strategy in epithelial ovarian cancer: Tumor-First or Germline-First?

4. Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysis.

5. Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.

6. Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy study.

7. Evaluation of treatment, prognostic factors, and survival in 198 vulvar melanoma patients: Implications for clinical practice.

8. Radiotherapy is not indicated in patients with vulvar squamous cell carcinoma and only one occult intracapsular groin node metastasis.

9. Fallopian tube abnormalities in uterine serous carcinoma.

10. The immune cell infiltrate in the microenvironment of vulvar Paget disease.

11. Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review.

12. Incidence and survival of glandular vulvar malignancies in the Netherlands.

13. Risk-reducing salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers: patients' and professionals' perspectives.

14. NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract--a study of 24 cases from the Netherlands.

15. Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls.

16. CA125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: a population-based study.

17. A patient with bilateral immature ovarian teratoma presenting with paraneoplastic encephalitis.

18. Letter commenting on the article "CA 125 expression pattern, prognosis and correlation with serum CA 125 in ovarian tumor patients" (104:508-515) by Hogdall, et al and on the Editorial "CA 125: megadaltons of novel opportunities" (104:505-507).

19. Patterns and frequency of recurrences of squamous cell carcinoma of the vulva.

Catalog

Books, media, physical & digital resources